Paraoxonase 1 and arylesterase levels in children with familial mediterranean fever

被引:0
|
作者
Kosan, C. [1 ]
Cayir, A. [2 ]
Turan, M. I. [2 ]
Ustebay, S. [2 ]
机构
[1] Ataturk Univ, Fac Med, Dept Pediat Nephrol, Erzurum, Turkey
[2] Ataturk Univ, Fac Med, Dept Pediat, Erzurum, Turkey
关键词
Familial Mediterranean Fever; Anti-oxidants; Paraoxonase; Arylesterase; ACUTE-PHASE RESPONSE; OXIDATIVE DNA-DAMAGE; DISEASE; STRESS; FMF;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: The pathogenesis of Familial Mediterranean Fever (FMF) is not clearly elucidated. It emerges as a result of triggering of the several environmental factors at the people who are genetically vulnerable. OBJECTIVES: To evaluate the anti-oxidant enzymes at the remission period of familial mediterranean fever (FMF). MATERIALS AND METHODS: Study group is consisted of 80 patients between the age of 2 and 16 years old who are routinely followed up. The control group is consisted of 80 healthy children whose physical examination is normal, and whose demographic findings are similar to the study group. Paraoxonase 1 (PON1) and arylesterase (ARE) levels are measured at both study and control group. RESULTS: The difference between the levels of ARE and PON1 are statistically significant between the FMF and control group (p = 0.007, p = 0.001). According to the weight scoring, ARE and PON1 levels of light cases are higher versus the levels of moderate cases (p < 0.01). CONCLUSIONS: Endogenous anti-oxidants Paraoxonase 1 and arylesterase levels are important in evaluating the inflammation at the remission period of FMF.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 50 条
  • [21] Familial Mediterranean Fever in older children
    Semanur Özdel
    Zeynep Birsin Özçakar
    Seda Sahin
    Mesiha Ekim
    Atilla Elhan
    Fatos Yalcinkaya
    Pediatric Rheumatology, 12 (Suppl 1)
  • [22] Arthritis in children with familial Mediterranean fever
    Ince, E
    Çakar, N
    Tekin, M
    Kendirli, T
    Özkaya, N
    Akar, N
    Yalçinkaya, F
    RHEUMATOLOGY INTERNATIONAL, 2002, 21 (06) : 213 - 217
  • [23] AMYLOIDOSIS IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER
    LUDOMIRSKY, A
    PASSWELL, J
    BOICHIS, H
    ARCHIVES OF DISEASE IN CHILDHOOD, 1981, 56 (06) : 464 - 467
  • [24] Paraoxonase and arylesterase levels in autoimmune thyroid diseases
    Korkmaz, Hakan
    Tabur, Suzan
    Ozkaya, Mesut
    Oguz, Elif
    Elboga, Umut
    Aksoy, Nurten
    Akarsu, Ersin
    REDOX REPORT, 2016, 21 (05) : 227 - 231
  • [25] Circulating thrombomodulin levels in familial Mediterranean fever
    Ozbalkan, Z.
    Ozturk, M. A.
    Onat, A. M.
    Ureten, K.
    Haznedaroglu, I. C.
    Kiraz, S.
    Ertenli, A. I.
    Kirazli, S.
    Calguneri, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : S95 - S98
  • [26] SUBCLINICAL INFLAMMATION IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER: MEASUREMENT OF SERUM AMYLOID A LEVELS
    Comak, E.
    Isiyel, E.
    Kilicbay, F.
    Aksoy, G. Kaya
    Gemici, A.
    Koyun, M.
    Akman, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 766 - 766
  • [27] Effect of Genotype on Plasma and Urinary Adrenomedullin Levels in Children with Familial Mediterranean Fever
    Kalman, Suleyman
    Sakallioglu, Onur
    Dogru, Ilker
    Gul, Davut
    Gok, Faysal
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (02): : 453 - 458
  • [28] Evaluation of hearing in familial Mediterranean fever children
    Talaat, Hala S.
    Shabana, Mohamed I.
    Hamdy, Mona M.
    Helmi, Heba A.
    Farag, Yomna M.
    EGYPTIAN RHEUMATOLOGIST, 2023, 45 (01): : 27 - 31
  • [29] Colchicine treatment in children with familial Mediterranean fever
    Özkaya, N
    Yalçinkaya, F
    CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) : 314 - 317
  • [30] Sacroiliitis in children and adolescents with familial Mediterranean fever
    Kacmaz, Hulya
    Aldemir, Esin
    Tanatar, Ayse
    Karadag, Serife Gul
    Cakan, Mustafa
    Sonmez, Hafize Emine
    Ayaz, Nuray Aktay
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)